Alx Oncology Holdings (ALXO) Treasury Shares (2019 - 2025)

Alx Oncology Holdings (ALXO) has 7 years of Treasury Shares data on file, last reported at $60750.0 in Q3 2025.

• For the quarter ending Q3 2025, Treasury Shares changed N/A year-over-year to $60750.0; the trailing twelve-month figure through Sep 2025 stood at $60750.0 (changed N/A YoY), and the FY2025 full-year result was $57750.0, down 95.4% from the prior year.
• Treasury Shares declined to $60750.0 in Q3 2025, from $69750.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $1.3 million in Q4 2024 to a low of $15075.0 in Q4 2021.
• A 5-year average of $510817.3 and a median of $496974.5 in 2022 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares soared 5341.63% in 2022 and rose 15.77% in 2023, its largest moves.
• Tracing ALXO's Treasury Shares over 5 years: stood at $15075.0 in 2021, then soared by 5341.63% to $820326.0 in 2022, then climbed by 15.77% to $949669.0 in 2023, then soared by 32.28% to $1.3 million in 2024, then slumped by 95.16% to $60750.0 in 2025.
• Business Quant data shows ALXO's Treasury Shares at $60750.0 in Q3 2025, $69750.0 in Q2 2025, and $72000.0 in Q1 2025.